Nexavar (R) (sorafenib) tablets received U.S. FDA approval for the treatment of patients with advanced kidney cancer. (PRNewsFoto/Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc.)
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
A source close to the Health Ministry confirmed that the price of a vital cancer medication in Lebanon is approximately twice what it is abroad, but defended the markup on economic grounds.The local price, which was confirmed by local pharmacists, is $3,735 for a pack of 60 tablets.The price of medication in Lebanon is determined by the Health Ministry in coordination with the manufacturer, the ministry's general director, Fouad Fleifil, confirmed. According to the Health Ministry's website, the only company licensed to import the medicine is Droguerie R. Pharaon & Fils S.A.LDarwish admitted that, while it was natural for the price in Lebanon to be slightly higher than it would be abroad, such a gap was unacceptable.
Casino Du Liban gets a taste of Puglia
Inventor hopes to incinerate Lebanon’s trash woes
Young athlete’s tragic death gives rise to ‘Young Heart’ foundation
FOLLOW THIS ARTICLE